When it comes to AstraZeneca, we have observed a great deal of interest from institutional investors, who have been buying the company’s calls. Secondly, HYG, a high yield bond, has observed a decrease in value as the rates went up. To capitalize on this, someone has purchased several April 72 put options. Lastly, the Apple trade is something to take note of; it keeps hitting the resistance around the 145-147 range, and on Friday, an individual purchased March 146 put options.
